Browse > Article

Cancer Chemopreventive Effects of Lactic Acid Bacteria  

Kim, Jong-Eun (Department of Agricultural Biotechnology, Seoul National University)
Kim, Ji-Yeon (Nutrition and Functional Food Headquarters, Korea Food and Drug Administration)
Lee, Ki-Won (Department of Bioscience and Biotechnology, Konkuk University)
Lee, Hyong-Joo (Department of Agricultural Biotechnology, Seoul National University)
Publication Information
Journal of Microbiology and Biotechnology / v.17, no.8, 2007 , pp. 1227-1235 More about this Journal
Abstract
Lactic acid bacteria (LAB) provide several potential health and nutritional benefits, including improving the nutritional value of food, controlling serum cholesterol levels, and controlling some types of cancer. Numerous in vitro, in vivo, human, and epidemiological studies have provided evidence of the chemopreventive effects of LAB on colon, bladder, liver, breast, and gastric cancers. These effects act via diverse mechanisms, including alteration of the gastrointestinal micro flora, enhancement of the host's immune response, and antioxidative and antiproliferative activities. This review discusses the recent progresses on the chemopreventive effects of LAB on specific cancer types and the underlying molecular mechanisms.
Keywords
Lactic acid bacteria; cancer; chemoprevetion;
Citations & Related Records
Times Cited By KSCI : 7  (Citation Analysis)
Times Cited By Web Of Science : 10  (Related Records In Web of Science)
연도 인용수 순위
1 Biffi, A., D. Coradini, R. Larsen, L. Riva, and G. Di Fronzo. 1997. Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr. Cancer 28: 93-99   DOI   ScienceOn
2 Chang, H. C., Y. D. Choi, and H. J. Lee. 1996. Molecular cloning of a $\beta$-D-galactosidase gene from Lactococcus lactis subsp. lactis 7962. J Microbiol. Biotechnol. 6: 386-390
3 Fujino, T. 2001. The tumor-preventing effect of a mixture of several lactic acid bacteria on 1,2-dimethylhydrazine-induced colon carcinogenesis in mice. Oncol. Rep. 8: 1073-1078
4 Gibson, G. R. and R. Fuller. 2000. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. J. Nutr. 130: 391S-395S
5 Goldin, B. R. and S. L. Gorbach. 1980. Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. J. Natl. Cancer Inst. 64: 263-265   DOI
6 Halliwell, B. 2007. Oxidative stress and cancer: Have we moved forward? Biochem. J. 401: 1-11   DOI   ScienceOn
7 Han, S. Y., C. S. Huh, Y. T. Ahn, K. S. Lim, Y. J. Baek, and D. H. Kim. 2005. Hepatoprotective effect of lactic acid bacteria, inhibitors of beta-glucuronidase production against intestinal microflora. Arch. Pharm. Res. 28: 325-329   과학기술학회마을   DOI
8 Hanahan, D. and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100: 57-70   DOI   ScienceOn
9 Jemal, A., R. Siegel, E. Ward, T. Murray, J. Xu, and M. J. Thun. 2007. Cancer statistics, 2007. CA Cancer J. Clin. 57: 43-66   DOI   ScienceOn
10 Kabir, A. M., Y. Aiba, A. Takagi, S. Kamiya, T. Miwa, and Y. Koga. 1997. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 41: 49-55   DOI   ScienceOn
11 Kim, J. E., D. W. Jeong, and H. J. Lee. 2007. Expression, purification, and characterization of arginine deiminase from Lactococcus lactis ssp. lactis ATCC 7962 in Escherichia coli BL21. Protein Expr. Purif. 53: 9-15   DOI   ScienceOn
12 Kim, J. Y., H. J. Woo, Y. S. Kim, and H. J. Lee. 2002. Screening for antiproliferative effects of cellular components from lactic acid bacteria against human cancer cell lines. Biotechnol. Lett. 24: 1431-1436   DOI   ScienceOn
13 Kim, S. Y., K. W. Lee, J. Y. Kim, and H. J. Lee. 2004. Cytoplasmic fraction of Lactococcus lactis ssp. lactis induces apoptosis in SNU-1 stomach adenocarcinoma cells. Biofactors 22: 119-122   DOI
14 Kim, Y., J. Y. Choi, K. M. Lee, S. K. Park, S. H. Ahn, D. Y. Noh, Y. C. Hong, D. Kang, and K. Y. Yoo. 2007. Dosedependent protective effect of breast-feeding against breast cancer among ever-lactated women in Korea. Eur. J. Cancer Prev. 16: 124-129   DOI   ScienceOn
15 Lee, J. M., J. Y. Choi, J. H. Lee, H. C. Chang, D. K. Chung, J. H. Kim, and H. J. Lee. 1999. Cloning and expression of the UDP-galactose-4-epimerase gene (galE) constituting the gal/lac operon of Lactococcus lactis ssp. lactis ATCC7962. J Microbiol. Biotechnol. 9: 393-397
16 Lee, K. H., J. Y. Park, S. J. Jeong, G. H. Kwon, H. J. Lee, H. C. Chang, D. K. Chung, J. H. Lee, and J. H. Kim. 2007. Characterization of paraplantaricin C7, a novel bacteriocin produced by Lactobacillus paraplantarum C7 isolated from kimchi. J. Microbiol. Biotechnol. 17: 287-296   과학기술학회마을
17 Oberfield, R. A., G. Steele Jr., J. L. Gollan, and D. Sherman. 1989. Liver cancer. CA Cancer J. Clin. 39: 206-218   DOI   ScienceOn
18 Park, S. Y., G. E. Ji, Y. T. Ko, H. K. Jung, Z. Ustunol, and J. J. Pestka. 1999. Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int. J. Food Microbiol. 46: 231-241   DOI   ScienceOn
19 Perdigon, G., M. E. de Macias, S. Alvarez, G. Oliver, and A. A. de Ruiz Holgado. 1986. Effect of perorally administered lactobacilli on macrophage activation in mice. Infect. Immun. 53: 404-410
20 Saito, H., H. Tomioka, and K. Nagashima. 1987. Protective and therapeutic efficacy of Lactobacillus casei against experimental murine infections due to Mycobacterium fortuitum complex. J. Gen. Microbiol. 133: 2843-2851
21 Yasui, H., K. Shida, T. Matsuzaki, and T. Yokokura. 1999. Immunomodulatory function of lactic acid bacteria. Antonie Van Leeuwenhoek 76: 383-389   DOI   ScienceOn
22 Surh, Y. J. 2003. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3: 768-780   DOI   ScienceOn
23 Tolley, D. A., M. K. B. Parmar, K. M. Grigor, and G. Lallemand. 1996. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: A further report with 7 years of followup. J. Urol. 155: 1233- 1238   DOI
24 van't Veer, P., J. M. Dekker, J. W. Lamers, F. J. Kok, E. G. Schouten, H. A. Brants, F. Sturmans, and R. J. Hermus. 1989. Consumption of fermented milk products and breast cancer: A case-control study in The Netherlands. Cancer Res. 49: 4020-4023
25 Guarner, F. and J.-R. Malagelada. 2003. Gut flora in health and disease. Lancet 361: 512-519   DOI   ScienceOn
26 Burns, A. J. and I. R. Rowland. 2004. Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells. Mutat. Res. 551: 233-243   DOI   ScienceOn
27 Kim, J. Y., H. J. Woo, Y. S. Kim, K. H. Kim, and H. J. Lee. 2003. Cell cycle dysregulation induced by cytoplasm of Lactococcus lactis ssp. lactis in SNUC2A, a colon cancer cell line. Nutr. Cancer 46: 197-201   DOI   ScienceOn
28 Lin, M. Y. and C. L. Yen. 1999. Antioxidative ability of lactic acid bacteria. J. Agric. Food Chem. 47: 1460-1466   DOI   ScienceOn
29 Perdigon, G., M. E. Nader de Macias, S. Alvarez, G. Oliver, and A. A. Pesce de Ruiz Holgado. 1987. Enhancement of immune response in mice fed with Streptococcus thermophilus and Lactobacillus acidophilus. J. Dairy Sci. 70: 919-926   DOI   ScienceOn
30 Gilliland, S. E. 1990. Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol. Rev. 7: 175-188   DOI   ScienceOn
31 Orrhage, K., E. Sillerstrom, J. A. Gustafsson, C. E. Nord, and J. Rafter. 1994. Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutat. Res. 311: 239-248   DOI   ScienceOn
32 Kubota, Y. 1990. Fecal intestinal flora in patients with colon adenoma and colon cancer. Nippon Shokakibyo Gakkai Zasshi 87: 771-779
33 Matsuzaki, T. 1998. Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int. J. Food Microbiol. 41: 133-140   DOI   ScienceOn
34 Bae, J. M., K. W. Jung, and Y. J. Won. 2002. Estimation of cancer deaths in Korea for the upcoming years. J. Korean Med. Sci. 17: 611-615   DOI
35 Ishikawa, H., I. Akedo, T. Otani, T. Suzuki, T. Nakamura, I. Takeyama, S. Ishiguro, E. Miyaoka, T. Sobue, and T. Kakizoe. 2005. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int. J. Cancer 116: 762-767   DOI   ScienceOn
36 Lin, D. C. 2003. Probiotics as functional foods. Nutr. Clin. Pract. 18: 497-506   DOI   ScienceOn
37 Seow, S. W., J. N. B. Rahmat, A. A. K. Mohamed, R. Mahendran, Y. K. Lee, and B. H. Bay. 2002. Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium bovis (Bacillus Calmette-Guerin). J. Urol. 168: 2236-2239   DOI   ScienceOn
38 Zhang, X. B. and Y. Ohta. 1991. Binding of mutagens by fractions of the cell wall skeleton of lactic acid bacteria on mutagens. J. Dairy Sci. 74: 1477-1481   DOI   ScienceOn
39 Peek, R. M. Jr. and M. J. Blaser. 2002. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2: 28-37   DOI   ScienceOn
40 Rokka, S., A. Pihlanto, H. Korhonen, and V. Joutsjoki. 2006. In vitro growth inhibition of Helicobacter pylori by lactobacilli belonging to the Lactobacillus plantarum group. Lett. Appl. Microbiol. 43: 508-513   DOI   ScienceOn
41 Pool-Zobel, B. L., B. Bertram, M. Knoll, R. Lambertz, C. Neudecker, U. Schillinger, P. Schmezer, and W. H. Holzapfel. 1993. Antigenotoxic properties of lactic acid bacteria in vivo in the gastrointestinal tract of rats. Nutr. Cancer 20: 271-281   DOI   ScienceOn
42 Lee, J. W., J. G. Shin, E. H. Kim, H. E. Kang, I. B. Yim, J. Y. Kim, H. G. Joo, and H. J. Woo. 2004. Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J. Vet. Sci. 5: 41-48
43 Cerutti, P. A. 1985. Prooxidant states and tumor promotion. Science 227: 375-381   DOI
44 Choi, S. S., Y. Kim, K. S. Han, S. You, S. Oh, and S. H. Kim. 2006. Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro. Lett. Appl. Microbiol. 42: 452-458   DOI   ScienceOn
45 Kim, T. S., J. W. Hur, M. A. Yu, C. I. Cheigh, K. N. Kim, J. K. Hwang, and Y. R. Pyun. 2003. Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J. Food Prot. 66: 3-12   DOI
46 Vanderhoof, J. A. and R. J. Young. 1998. Use of probiotics in childhood gastrointestinal disorders. J. Pediatr. Gastroenterol. Nutr. 27: 323-332   DOI   ScienceOn
47 Lim, B. K., R. Mahendran, Y. K. Lee, and B. H. Bay. 2002. Chemopreventive effect of Lactobacillus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the mouse. Jpn. J. Cancer Res. 93: 36-41   DOI
48 Lin, M. Y. and C. L. Yen. 1999. Inhibition of lipid peroxidation by Lactobacillus acidophilus and Bifidobacterium longum. J. Agric. Food Chem. 47: 3661-3664   DOI   ScienceOn
49 Hur, H. J., K. W. Lee, H. Y. Kim, D. K. Chung, and H. J. Lee. 2006. In vitro immunopotentiating activities of cellular fractions of lactic acid bacteria isolated from kimchi and Bifidobacteria. J. Microbiol. Biotechnol. 16: 661-666   과학기술학회마을
50 Lee, J. E., G. J. Woo, and H. J. Lee. 1996. Tetramethylpyrazine production by immobilized culture of Lactococcus lactis subsp. lactis biovar. diacetilactis FC1. J Microbiol. Biotechnol. 6: 137-141
51 Park, I. S., Y. C. Lee, H. J. Park, T. I. Kim, S. I. Lee, H. Kim, K. S. Chung, and Y. C. Lee-Kim. 2001. Helicobacter pylori infection in Korea. Yonsei Med. J. 42: 457-470   DOI
52 Singh, J., A. Rivenson, M. Tomita, S. Shimamura, N. Ishibashi, and B. S. Reddy. 1997. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18: 833-841   DOI   ScienceOn
53 Sellers, W. R. and D. E. Fisher. 1999. Apoptosis and cancer drug targeting. J. Clin. Invest. 104: 1655-1661   DOI   ScienceOn
54 Lorca, G. L., T. Wadstrom, G. F. Valdez, and A. Ljungh. 2001. Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr. Microbiol. 42: 39-44   DOI   ScienceOn
55 Reddy, B. S. and A. Rivenson. 1993. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5- f]quinoline, a food mutagen. Cancer Res. 53: 3914-3918
56 Yasutake, N., T. Matsuzaki, K. Kimura, S. Hashimoto, T. Yokokura, and Y. Yoshikai. 1999. The role of tumor necrosis factor (TNF)-alpha in the antitumor effect of intrapleural injection of Lactobacillus casei strain Shirota in mice. Med. Microbiol. Immunol. 188: 9-14   DOI   ScienceOn
57 Bae, E. A., D. H. Kim, and M. J. Han. 2000. Anti- Helicobacter pylori activity of Bifidobacterium spp. J Microbiol. Biotechnol. 10: 532-534
58 Kim, D. W., Y. J. Bang, D. S. Heo, and N. K. Kim. 2002. Colorectal cancer in Korea: Characteristics and trends. Tumori 88: 262-265   DOI
59 Kim, J. Y., S. Lee, D. W. Jeong, S. Hachimura, S. Kaminogawa, and H. J. Lee. 2005. Effects of intraperitoneal administration of Lactococcus lactis ssp. lactis cellular fraction on immune response. Food Sci. Biotechnol. 14: 405-409
60 Rowland, I. R., C. J. Rumney, J. T. Coutts, and L. C. Lievense. 1998. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19: 281-285   DOI   ScienceOn
61 Hur, H. J., K. W. Lee, and H. J. Lee. 2004. Production of nitric oxide, tumor necrosis factor-alpha and interleukin-6 by RAW264.7 macrophage cells treated with lactic acid bacteria isolated from kimchi. Biofactors 21: 123-125   DOI
62 Felley, C. and P. Michetti. 2003. Probiotics and Helicobacter pylori. Best Pract. Res. Clin. Gastroenterol. 17: 785-791   DOI
63 Kato, I., T. Yokokura, and M. Mutai. 1988. Correlation between increase in Ia-bearing macrophages and induction of T cell-dependent antitumor activity by Lactobacillus casei in mice. Cancer Immunol. Immunother. 26: 215-221
64 Lee, H. M. and Y. Lee. 2006. Isolation of Lactobacillus plantarum from kimchi and its inhibitory activity on the adherence and growth of Helicobacter pylori. J Microbiol. Biotechnol. 16: 1513-1517   과학기술학회마을
65 Aso, Y. and H. Akazan. 1992. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Urol. Int. 49: 125-129   DOI   ScienceOn
66 El-Nezami, H. S., N. N. Polychronaki, J. Ma, H. Zhu, W. Ling, E. K. Salminen, R. O. Juvonen, S. J. Salminen, T. Poussa, and H. M. Mykkanen. 2006. Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. Am. J. Clin. Nutr. 83: 1199-1203   DOI
67 Sekine, K., T. Kawashima, and Y. Hashimoto. 1994. Comparison of the TNF-$\alpha$ levels induced by human-derived Bifidobacterium longum and rat-derived Bifidobacterium animalis in mouse peritoneal cells. Bifidobacteria Microflora 13: 79-89   DOI
68 Lee, K. W. and H. J. Lee. 2006. The roles of polyphenols in cancer chemoprevention. Biofactors 26: 105-121   DOI
69 Kato, I., T. Yokokura, and M. Mutai. 1983. Macrophage activation by Lactobacillus casei in mice. Microbiol. Immunol. 27: 611-618   DOI
70 Stiles, M. E. and W. H. Holzapfel. 1997. Lactic acid bacteria of foods and their current taxonomy. Int. J. Food Microbiol. 36: 1-29   DOI   ScienceOn
71 Teitelbaum, J. E. and W. A. Walker. 2002. Nutritional impact of pre- and probiotics as protective gastrointestinal organisms. Annu. Rev. Nutr. 22: 107-138   DOI   ScienceOn
72 Chang, J. H., J. H. Shin, I. S. Chung, and H. J. Lee. 1999. Improved menthol production using suspension cultures of Mentha piperita with pectinase elicitation. J. Microbiol. Biotechnol. 9: 358-360
73 Kim, J. Y., S. Lee, D. W. Jeong, S. Hachimura, S. Kaminogawa, and H. J. Lee. 2006. In vivo immunopotentiating effects of cellular components from Lactococcus lactis ssp. lactis. J Microbiol. Biotechnol. 16: 786-790   과학기술학회마을
74 Ohashi, Y., S. Nakai, T. Tsukamoto, N. Masumori, H. Akaza, N. Miyanaga, T. Kitamura, K. Kawabe, T. Kotake, M. Kuroda, S. Naito, H. Koga, Y. Saito, K. Nomata, M. Kitagawa, and Y. Aso. 2002. Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol. Int. 68: 273-280   DOI   ScienceOn
75 Park, A., A. Rae-Jun, K. H. Lee, S. J. Kim, J. Y. Park, S. J. Nam, H. D. Yun, H. J. Lee, H. C. Chang, D. K. Chung, J. H. Lee, Y. H. Park, and J. H. Kim. 2002. Isolation of Lactococcus lactis strain with $\beta$-galactosidase activity from kimchi and cloning of lacZ gene from the isolated strain. J Microbiol. Biotechnol. 12: 157-161
76 Rafter, J., M. Bennett, G. Caderni, Y. Clune, R. Hughes, P. C. Karlsson, A. Klinder, M. O'Riordan, G. C. O'Sullivan, B. Pool-Zobel, G. Rechkemmer, M. Roller, I. Rowland, M. Salvadori, H. Thijs, J. Van Loo, B. Watzl, and J. K. Collins. 2007. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 85: 488-496   DOI
77 Baricault, L., G. Denariaz, J. J. Houri, C. Bouley, C. Sapin, and G. Trugnan. 1995. Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation. Carcinogenesis 16: 245-252   DOI   ScienceOn
78 Goldin, B. and S. L. Gorbach. 1977. Alterations in fecal microflora enzymes related to diet, age, Lactobacillus supplements, and dimethylhydrazine. Cancer 40: 2421- 2426   DOI   ScienceOn
79 Kaizu, H., M. Sasaki, H. Nakajima, and Y. Suzuki. 1993. Effect of antioxidative lactic acid bacteria on rats fed a diet deficient in vitamin E. J. Dairy Sci. 76: 2493-2499   DOI   ScienceOn
80 Lee, K. W., H. J. Lee, H. Y. Cho, and Y. J. Kim. 2005. Role of the conjugated linoleic acid in the prevention of cancer. Crit. Rev. Food Sci. Nutr. 45: 135-144   DOI   ScienceOn
81 Sporn, M. B. and N. Suh. 2000. Chemoprevention of cancer. Carcinogenesis 21: 525-530   DOI   ScienceOn
82 Nanji, A. A., U. Khettry, and S. M. Sadrzadeh. 1994. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc. Soc. Exp. Biol. Med. 205: 243-247
83 Sengupta, N., E. Siddiqui, and F. H. Mumtaz. 2004. Cancers of the bladder. J. R. Soc. Health 124: 228-229   DOI   ScienceOn
84 Agha-Mohammadi, S. and M. T. Lotze. 2000. Immunomodulation of cancer: Potential use of selectively replicating agents. J. Clin. Invest. 105: 1173-1176   DOI   ScienceOn
85 de Moreno de LeBlanc, A., C. Matar, N. LeBlanc, and G. Perdigon. 2005. Effects of milk fermented by Lactobacillus helveticus R389 on a murine breast cancer model. Breast Cancer Res. 7: R477-R486   DOI
86 Gotteland, M. and S. Cruchet. 2003. Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on Helicobacter pylori colonization in asymptomatic volunteers. J. Antimicrob. Chemother. 51: 1317-1319   DOI   ScienceOn
87 Lin, M. Y. and F. J. Chang. 2000. Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig. Dis. Sci. 45: 1617-1622   DOI   ScienceOn
88 Sgouras, D., P. Maragkoudakis, K. Petraki, B. Martinez- Gonzalez, E. Eriotou, S. Michopoulos, G. Kalantzopoulos, E. Tsakalidou, and A. Mentis. 2004. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl. Environ. Microbiol. 70: 518-526   DOI   ScienceOn
89 Goldin, B. R. and S. L. Gorbach. 1984. The effect of milk and Lactobacillus feeding on human intestinal bacterial enzyme activity. Am. J. Clin. Nutr. 39: 756-761   DOI
90 Clausen, M. R. and P. B. Mortensen. 1997. Lactulose, disaccharides and colonic flora. Clinical consequences. Drugs 53: 930-942   DOI   ScienceOn
91 Lankaputhra, W. E. and N. P. Shah. 1998. Antimutagenic properties of probiotic bacteria and of organic acids. Mutat. Res. 397: 169-182   DOI   ScienceOn
92 Kulkarni, N. and B. S. Reddy. 1994. Inhibitory effect of Bifidobacterium longum cultures on the azoxymethaneinduced aberrant crypt foci formation and fecal bacterial beta-glucuronidase. Proc. Soc. Exp. Biol. Med. 207: 278-283